ONECUT2: ATargetable Master Regulator of Progression to Neuroendocrine Differentiation from Prostate Adenocarcinoma

被引：0
|
作者：
Rotinen, Mirja [1 ]
You, Sungyong [1 ]
Yang, Julie [1 ]
Coetzee, Simon [1 ]
Huang, Wen-Chin [1 ,2 ]
Huang, Fangjin [1 ]
Pan, Xinlei [1 ]
Yanez, Alberto [1 ]
Hazelett, Dennis [1 ]
Chu, Chia-Yi [1 ]
Chung, Leland [1 ]
Di Vizio, Dolores [1 ]
Garraway, Isla [3 ]
Murali, Ramachandran [1 ]
Knudsen, Beatrice [1 ]
Freeman, Michael [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] China Med Univ, Taichung, Taiwan
[3] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
PANCREAS | 2018年 / 47卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：353 / 354
页数：2
相关论文
共 50 条
  • [21] Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation
    Minagawa, Hideyuki
    Kawai, Taketo
    Matsumoto, Akihiko
    Makino, Katsuhiro
    Sato, Yusuke
    Nagasaka, Kenji
    Tokura, Masami
    Tanaka, Nao
    Ito, Eisaku
    Yamada, Yuta
    Nakamura, Masaki
    Yamada, Daisuke
    Suzuki, Motofumi
    Murata, Takashi
    Kume, Haruki
    BMC UROLOGY, 2021, 21 (01)
  • [22] Activation of ONECUT2 by RB1 loss in castration-resistant prostate cancer
    Qian, Chen
    Yang, Qian
    Freedland, Stephen J.
    Di Vizio, Dolores
    Ellis, Leigh
    You, Sungyong
    Freeman, Michael R.
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2022, 10 (06): : 397 - 407
  • [23] Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation
    Hideyuki Minagawa
    Taketo Kawai
    Akihiko Matsumoto
    Katsuhiro Makino
    Yusuke Sato
    Kenji Nagasaka
    Masami Tokura
    Nao Tanaka
    Eisaku Ito
    Yuta Yamada
    Masaki Nakamura
    Daisuke Yamada
    Motofumi Suzuki
    Takashi Murata
    Haruki Kume
    BMC Urology, 21
  • [24] The prognostic value of neuroendocrine differentiation in adenocarcinoma of the prostate in relation to progression of disease after endocrine therapy
    Krijnen, JLM
    Bogdanowicz, JFAT
    Seldenrijk, CA
    Mulder, PGH
    vanderKwast, TH
    JOURNAL OF UROLOGY, 1997, 158 (01): : 171 - 174
  • [25] Relation of prostate adenocarcinoma neuroendocrine differentiation to Gleason system
    Marcu, M.
    Radu, E.
    Plesea, R. M.
    Plesea, I. E.
    VIRCHOWS ARCHIV, 2017, 471 : S286 - S286
  • [26] Prognostic role of neuroendocrine differentiation marker in prostate adenocarcinoma
    Zhu, Menglei
    Chen, Wei
    Glover, Michael
    Shankar, Eswar
    MacLennan, Gregory T.
    Gupta, Sanjay
    CANCER RESEARCH, 2017, 77
  • [27] ONECUT2 activates diverse resistance drivers of androgen receptor-independent heterogeneity in prostate cancer
    Qian, Chen
    Yang, Qian
    Rotinen, Mirja
    Huang, Rongrong
    Kim, Hyoyoung
    Gallent, Brad
    Yan, Yiwu
    Cadaneanu, Radu M.
    Zhang, Baohui
    Kaochar, Salma
    Freedland, Stephen J.
    Posadas, Edwin M.
    Ellis, Leigh
    Di Vizio, Dolores
    Morrissey, Colm
    Nelson, Peter S.
    Brady, Lauren
    Murali, Ramachandran
    Campbell, Moray J.
    Yang, Wei
    Knudsen, Beatrice S.
    Mostaghel, Elahe A.
    Ye, Huihui
    Garraway, Isla P.
    You, Sungyong
    Freeman, Michael R.
    CANCER RESEARCH, 2024, 84 (06)
  • [28] New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma
    Sciarra, A
    Cardi, A
    Dattilo, C
    Mariotti, G
    Di Monaco, F
    Di Silverio, F
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (04) : 462 - 470
  • [29] The many faces of neuroendocrine differentiation in prostate cancer progression
    Terry, Stephane
    Beltran, Himisha
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [30] Molecular mechanisms of neuroendocrine differentiation in prostate cancer progression
    Yuchen Xie
    Songyi Ning
    Jianpeng Hu
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 1813 - 1823
12345